Correction: The impact of cancer diagnosis on functional decline in adults aged 50 and older: the US Health and Retirement Study

By afschroeder • August 29, 2025

Nam GE, Mayeda ER, Pan Y, Hayes-Larson E, Rojas-Saunero LP, Zhou H, Rao JY, Zhang ZF. Correction: The impact of cancer diagnosis on functional decline in adults aged 50 and older: the US Health and Retirement Study. J Cancer Surviv. 2025 Aug 28. doi: 10.1007/s11764-025-01884-4. Epub ahead of print. Erratum for: J Cancer Surviv. 2025 Jul 29. doi: 10.1007/s11764-025-01867-5. PMID: 40875142.

Tags: Clinical Trials, Publications

Study of Pembrolizumab (MK-3475) Subcutaneous (SC) Versus Pembrolizumab Intravenous (IV) Administered With Platinum Doublet Chemotherapy in Participants With Metastatic Squamous or Nonsquamous Non-Small Cell Lung Cancer (NSCLC) (MK-3475-A86)

Brief Summary The purpose of this study is to evaluate pembrolizumab (MK-3475) subcutaneous (SC) administration as the first-line therapy in the treatment of metastatic squamous[...]

Virtual Reality Experience for Stress Reduction in Cardiology Patients

Brief Summary The purpose of the research is to evaluate the feasibility and scalability of delivering a 30-minute novel virtual reality (VR) experience through the[...]

Adalimumab vs. Conventional Immunosuppression for Uveitis Trial

Brief Summary Non-infectious intermediate, posterior, and panuveitides are chronic, potentially-blinding diseases. Vision-threatening cases require long-term therapy with oral corticosteroids and immunosuppression. Based upon preliminary data,[...]